TPG is estimated to be sitting on 18.5 per cent unrealised gains on its three-year-old investment in Shriram Capital.
The venture capital firm is floating its third fund with a target corpus of Rs 500 crore.
Alivira is a joint venture between SeQuent Scientific and Shasun Pharma.
Axiall is a manufacturer of chlorovinyls and aromatics with annual revenues of around $5 billion.
The project is expected to be launched by June this year.
The NBFC is backed by IFC, Warburg Pincus, ChrysCap and Motilal Oswal Group.
IT services major HCL Technologies, followed its larger peers TCS and Infosys to churn solid earnings in the fourth quarter, beating street expectations with 59 per cent rise in net profit. Its revenues also rose a robust 30 per cent.
The head of the beauty services and products company says going forward the products unit will generate 25 per cent of revenue against 20 per cent now.
The founder and CEO of the PE firm says the deal with India Infoline took a long time to seal, which affected new investments.
Unlike Nalanda, Cartica appears to be buying at the top end of valuations. Most likely the fund will end up losing...
Congrats the completion of the deal between Manipal Health enterprises and SK Soni. It gives us the unique...
PIFA has been at the forefront as the the landscape for football changes in India. We are privileged to have a team...
Country Club has a very unsavoury reputation what with its unscrupulous selling methods using boiler room...